Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05549739

Enrollment

Registered

2022-09-22

Start date

2022-09-23

Completion date

2022-11-30

Last updated

2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

respiratory function test, physical functional performance, coronary artery disease

Brief summary

The purpose of this study is to evaluate respiratory parameters and functional capacity in coronary artery patients.

Detailed description

Decreased pulmonary function as measured by forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), or peak expiratory flow (PEF) has been associated with an increased risk of cardiovascular mortality and morbidity. A low MIP value may generally indicate weak muscle strength and therefore be an indicator of general poor health. Respiratory muscle weakness and decreased respiratory muscle endurance affect exercise tolerance in individuals with chronic disease, including cardiovascular disease. Studies have supported the association of grip strength with frailty, physical activity, diabetes, functional limitation, nutritional status, metabolic syndrome, and mortality. The study will evaluate respiratory parameters and functional capacity in coronary artery patients.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

41 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients with coronary artery disease * Volunteering to participate in the research

Exclusion criteria

* Having a musculoskeletal problem * Having unstable cardiac disease * Having chronic heart failure (NYHA III-IV) * A history of acute coronary syndrome or surgical revascularization less than 3 months ago * Having arrhythmia * Having the last stage of kidney disease * Having active myocarditis or pericarditis

Design outcomes

Primary

Measure	Time frame	Description
Six-minute-step test	Day 1	The number of steps the participant climbed up and down is recorded.
Respiratory muscle strength	Day 1	Respiratory muscle strength will be evaluated using a mouth pressure device.
Respiratory muscle endurance	Day 1	Respiratory muscle endurance will be evaluated using a constant load test.

Secondary

Measure	Time frame	Description
Pulmonary functions	Day 1	Forced vital capacity (FVC), Forced expiratory volume at one second (FEV1), Peak expiratory flow (PEF) assessment via spirometry.
Hand grip strength	Day 1	Hand grip strength is evaluated by a hand dynamometer.
Functional Capasity	Day 1	The functional capacity is assessed with The Duke Activity Status Index (DASI).

Countries

Turkey (Türkiye)

Outcome results